{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:24:39Z","timestamp":1793381079293,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Yunnan Xingdian Talents Support Program"},{"name":"Yunnan Basic Research Project","award":["[202301AT070187]"],"award-info":[{"award-number":["[202301AT070187]"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-82392-w","type":"journal-article","created":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T12:24:29Z","timestamp":1744028669000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Application of peritumoral radiomics based on simulated positioning CT images in the prognosis of intermediate-advanced esophageal cancer"],"prefix":"10.1038","volume":"15","author":[{"given":"Ruiling","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinqiu","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruimin","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizhu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,7]]},"reference":[{"issue":"3","key":"82392_CR1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71 (3), 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"issue":"5","key":"82392_CR2","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1002\/cam4.3647","volume":"10","author":"F He","year":"2021","unstructured":"He, F. et al. Esophageal cancer: trends in incidence and mortality in China from 2005 to 2015. Cancer Med. 10 (5), 1839\u20131847 (2021).","journal-title":"Cancer Med."},{"issue":"9","key":"82392_CR3","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S1470-2045(15)00040-6","volume":"16","author":"J Shapiro","year":"2015","unstructured":"Shapiro, J. et al. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol. 16 (9), 1090\u20131098 (2015).","journal-title":"Lancet Oncol."},{"issue":"27","key":"82392_CR4","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1200\/JCO.2018.79.1483","volume":"36","author":"H Yang","year":"2018","unstructured":"Yang, H. et al. Neoadjuvant Chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of the Esophagus (NEOCRTEC5010): a phase III Multicenter, Randomized, open-label clinical trial. J. Clin. Oncol. 36 (27), 2796\u20132803 (2018).","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"82392_CR5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.rcl.2020.11.008","volume":"59","author":"SL Betancourt-Cuellar","year":"2021","unstructured":"Betancourt-Cuellar, S. L. et al. Esophageal Cancer: tumor-node-metastasis staging. Radiol. Clin. North Am. 59 (2), 219\u2013229 (2021).","journal-title":"Radiol. Clin. North Am."},{"issue":"5","key":"82392_CR6","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s00268-006-0551-1","volume":"31","author":"G Chen","year":"2007","unstructured":"Chen, G. et al. Recurrence pattern of squamous cell carcinoma in the middle thoracic esophagus after modified Ivor-Lewis esophagectomy. World J. Surg. 31 (5), 1107\u20131114 (2007).","journal-title":"World J. Surg."},{"issue":"5","key":"82392_CR7","doi-asserted-by":"crossref","first-page":"e97225","DOI":"10.1371\/journal.pone.0097225","volume":"9","author":"Q Liu","year":"2014","unstructured":"Liu, Q. et al. Patterns of failure after radical surgery among patients with thoracic esophageal squamous cell carcinoma: implications for the clinical target volume design of postoperative radiotherapy. PLoS One. 9 (5), e97225 (2014).","journal-title":"PLoS One"},{"issue":"2","key":"82392_CR8","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jamcollsurg.2003.10.005","volume":"198","author":"S Nakagawa","year":"2004","unstructured":"Nakagawa, S. et al. Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy. J. Am. Coll. Surg. 198 (2), 205\u2013211 (2004).","journal-title":"J. Am. Coll. Surg."},{"issue":"1","key":"82392_CR9","doi-asserted-by":"crossref","first-page":"100789","DOI":"10.1016\/j.esmoop.2023.100789","volume":"8","author":"HC Puhr","year":"2023","unstructured":"Puhr, H. C., Prager, G. W. & Ilhan-Mutlu, A. How we treat esophageal squamous cell carcinoma. ESMO Open. 8 (1), 100789 (2023).","journal-title":"ESMO Open."},{"issue":"10","key":"82392_CR10","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/cac2.12087","volume":"40","author":"Y He","year":"2020","unstructured":"He, Y. et al. Clinical characteristics and survival of 5283 esophageal cancer patients: a multicenter study from eighteen hospitals across six regions in China. Cancer Commun. (Lond). 40 (10), 531\u2013544 (2020).","journal-title":"Cancer Commun. (Lond)"},{"issue":"1","key":"82392_CR11","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s40644-021-00407-5","volume":"21","author":"S Tang","year":"2021","unstructured":"Tang, S. et al. Application of contrast-enhanced CT radiomics in prediction of early recurrence of locally advanced oesophageal squamous cell carcinoma after trimodal therapy. Cancer Imaging. 21 (1), 38 (2021).","journal-title":"Cancer Imaging"},{"issue":"1","key":"82392_CR12","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13014-022-02053-y","volume":"17","author":"P Bonomo","year":"2022","unstructured":"Bonomo, P. et al. Simulation CT-based radiomics for prediction of response after neoadjuvant chemo-radiotherapy in patients with locally advanced rectal cancer. Radiat. Oncol. 17 (1), 84 (2022).","journal-title":"Radiat. Oncol."},{"key":"82392_CR13","doi-asserted-by":"crossref","first-page":"689802","DOI":"10.3389\/fonc.2021.689802","volume":"11","author":"H Ding","year":"2021","unstructured":"Ding, H. et al. Radiomics in Oncology: a 10-Year bibliometric analysis. Front. Oncol. 11, 689802 (2021).","journal-title":"Front. Oncol."},{"issue":"10","key":"82392_CR14","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1007\/s00330-017-4815-y","volume":"27","author":"P Prasanna","year":"2017","unstructured":"Prasanna, P. et al. Erratum to: Radiomic features from the peritumoral brain parenchyma on treatment-naive multi-parametric MR imaging predict long versus short-term survival in glioblastoma multiforme: preliminary findings. Eur. Radiol. 27 (10), 4198\u20134199 (2017).","journal-title":"Eur. Radiol."},{"issue":"11","key":"82392_CR15","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1016\/j.celrep.2017.11.052","volume":"21","author":"J Faget","year":"2017","unstructured":"Faget, J. et al. Neutrophils and snail orchestrate the establishment of a Pro-tumor Microenvironment in Lung Cancer. Cell. Rep. 21 (11), 3190\u20133204 (2017).","journal-title":"Cell. Rep."},{"issue":"2","key":"82392_CR16","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41571-021-00560-7","volume":"19","author":"K Bera","year":"2022","unstructured":"Bera, K. et al. Predicting cancer outcomes with radiomics and artificial intelligence in radiology. Nat. Rev. Clin. Oncol. 19 (2), 132\u2013146 (2022).","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"5","key":"82392_CR17","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.7150\/thno.30309","volume":"9","author":"Z Liu","year":"2019","unstructured":"Liu, Z. et al. The applications of Radiomics in Precision diagnosis and treatment of Oncology: opportunities and challenges. Theranostics 9 (5), 1303\u20131322 (2019).","journal-title":"Theranostics"},{"issue":"4","key":"82392_CR18","doi-asserted-by":"crossref","first-page":"e192561","DOI":"10.1001\/jamanetworkopen.2019.2561","volume":"2","author":"N Braman","year":"2019","unstructured":"Braman, N. et al. Association of Peritumoral Radiomics with Tumor Biology and pathologic response to Preoperative targeted therapy for HER2 (ERBB2)-Positive breast Cancer. JAMA Netw. Open. 2 (4), e192561 (2019).","journal-title":"JAMA Netw. Open."},{"key":"82392_CR19","doi-asserted-by":"crossref","unstructured":"Bennani-Baiti, B. et al. Non-invasive Assessment of Hypoxia and Neovascularization with MRI for identification of aggressive breast Cancer. Cancers (Basel) ;12(8), 2024 (2020).","DOI":"10.3390\/cancers12082024"},{"issue":"2","key":"82392_CR20","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ijrobp.2021.04.047","volume":"111","author":"L Wang","year":"2021","unstructured":"Wang, L. et al. Computed tomography-based Delta-Radiomics analysis for discriminating Radiation pneumonitis in patients with Esophageal Cancer after Radiation Therapy. Int. J. Radiat. Oncol. Biol. Phys. 111 (2), 443\u2013455 (2021).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"82392_CR21","doi-asserted-by":"crossref","unstructured":"Beukinga, R. J. et al. Prediction of non-response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer patients with (18)F-FDG PET Radiomics Based Machine Learning classification. Diagnostics (Basel) ;12(5), 1070 (2022).","DOI":"10.3390\/diagnostics12051070"},{"key":"82392_CR22","doi-asserted-by":"crossref","first-page":"1082960","DOI":"10.3389\/fonc.2023.1082960","volume":"13","author":"H Guo","year":"2023","unstructured":"Guo, H. et al. The application of radiomics in esophageal cancer: Predicting the response after neoadjuvant therapy. Front. Oncol. 13, 1082960 (2023).","journal-title":"Front. Oncol."},{"issue":"2","key":"82392_CR23","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1007\/s00330-018-5583-z","volume":"29","author":"J Qu","year":"2019","unstructured":"Qu, J. et al. The MR radiomic signature can predict preoperative lymph node metastasis in patients with esophageal cancer. Eur. Radiol. 29 (2), 906\u2013914 (2019).","journal-title":"Eur. Radiol."},{"issue":"2","key":"82392_CR24","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2174\/1389202923666220214122506","volume":"23","author":"Y Yao","year":"2022","unstructured":"Yao, Y., Zhang, S. & Xue, T. Integrating LASSO Feature Selection and Soft Voting Classifier to identify origins of Replication sites. Curr. Genomics. 23 (2), 83\u201393 (2022).","journal-title":"Curr. Genomics"},{"issue":"8","key":"82392_CR25","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/RLU.0000000000004253","volume":"47","author":"R Anconina","year":"2022","unstructured":"Anconina, R. et al. Combined 18 F-FDG PET\/CT Radiomics and Sarcopenia score in Predicting Relapse-Free Survival and overall survival in patients with Esophagogastric Cancer. Clin. Nucl. Med. 47 (8), 684\u2013691 (2022).","journal-title":"Clin. Nucl. Med."},{"key":"82392_CR26","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ebiom.2019.05.023","volume":"44","author":"C Xie","year":"2019","unstructured":"Xie, C. et al. Sub-region based radiomics analysis for survival prediction in oesophageal tumours treated by definitive concurrent chemoradiotherapy. EBioMedicine 44, 289\u2013297 (2019).","journal-title":"EBioMedicine"},{"issue":"9","key":"82392_CR27","doi-asserted-by":"crossref","first-page":"5930","DOI":"10.1007\/s00330-022-08776-6","volume":"32","author":"F Chu","year":"2022","unstructured":"Chu, F. et al. Development and validation of MRI-based radiomics signatures models for prediction of disease-free survival and overall survival in patients with esophageal squamous cell carcinoma. Eur. Radiol. 32 (9), 5930\u20135942 (2022).","journal-title":"Eur. Radiol."},{"issue":"6","key":"82392_CR28","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jtho.2023.01.089","volume":"18","author":"M Chen","year":"2023","unstructured":"Chen, M. et al. A Novel Radiogenomics Biomarker for Predicting Treatment response and pneumotoxicity from programmed cell death protein or Ligand-1 inhibition immunotherapy in NSCLC. J. Thorac. Oncol. 18 (6), 718\u2013730 (2023).","journal-title":"J. Thorac. Oncol."},{"issue":"1","key":"82392_CR29","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s13014-022-02154-8","volume":"17","author":"Y Huang","year":"2022","unstructured":"Huang, Y. et al. Radiation pneumonitis prediction after stereotactic body radiation therapy based on 3D dose distribution: dosiomics and\/or deep learning-based radiomics features. Radiat. Oncol. 17 (1), 188 (2022).","journal-title":"Radiat. Oncol."},{"key":"82392_CR30","doi-asserted-by":"crossref","unstructured":"Alvarez-Jimenez, C. et al. Identifying Cross-scale associations between Radiomic and Pathomic signatures of Non-small Cell Lung Cancer subtypes: preliminary results. Cancers (Basel) 12(12), 3663 (2020).","DOI":"10.3390\/cancers12123663"},{"issue":"11","key":"82392_CR31","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s11912-020-00975-y","volume":"22","author":"G Terrero","year":"2020","unstructured":"Terrero, G. & Lockhart, A. C. Role of Immunotherapy in Advanced Gastroesophageal Cancer. Curr. Oncol. Rep. 22 (11), 112 (2020).","journal-title":"Curr. Oncol. Rep."},{"issue":"10","key":"82392_CR32","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1001\/jama.2021.12836","volume":"326","author":"H Luo","year":"2021","unstructured":"Luo, H. et al. Effect of Camrelizumab vs Placebo added to Chemotherapy on Survival and Progression-Free Survival in patients with Advanced or metastatic esophageal squamous cell carcinoma: the ESCORT-1st Randomized Clinical Trial. JAMA 326 (10), 916\u2013925 (2021).","journal-title":"JAMA"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-82392-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-82392-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-82392-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T12:25:48Z","timestamp":1744028748000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-82392-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,7]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["82392"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-82392-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,7]]},"assertion":[{"value":"14 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Ethics Committee of The Third Affiliated Hospital of Kunming Medical University (Yunnan Cancer Hospital & Yunnan Cancer Center) before the commencement of the research. All participants had implemented informed consent and signed the informed consent before the investigation.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"11865"}}